Open Access
Zanamivir in the Prevention of Influenza Among Healthy Adults
Reads0
Chats0
TLDR
Zanamivir administered once daily is efficacious and well tolerated in the prevention of influenza for a 4-week period in healthy adults.About:
The article was published on 2017-01-01 and is currently open access. It has received 288 citations till now. The article focuses on the topics: Zanamivir.read more
Citations
More filters
Journal Article
Prevention and control of influenza : recommendations of the Advisory Committee on Immunization Practices (ACIP)
TL;DR: This report updates the 2000 recommendations by the Advisory Committee on Immunization Practices on the use of influenza vaccine and antiviral agents with new or updated information regarding the cost-effectiveness of influenza vaccination and the 2001-2002 trivalent vaccine virus strains.
Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia the official statement of the American Thoracic Society and the Infectious Disease Society of America (特集 救急診療ガイドライン) -- (海外のガイドライン)
TL;DR: The Methodology used to Prepare the Guideline Epidemiology Incidence Etiology and Recommendations for Assessing Response to Therapy Suggested Performance Indicators is summarized.
Journal ArticleDOI
Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention.
Michael S. Niederman,Lionel A. Mandell,Antonio Anzueto,J. B. Bass,W. A. Broughton,G. D. Campbell,Nathan C. Dean,Thomas M. File,Michael J. Fine,Peter A. Gross,Fernando J. Martinez,Thomas J. Marrie,Joseph F. Plouffe,Josep Ramírez,G. A. Sarosi,Antoni Torres,Robert Wilson,Victor L. Yu +17 more
Journal ArticleDOI
Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective.
Marcie Tomblyn,Tom Chiller,Hermann Einsele,Ronald E. Gress,Kent A. Sepkowitz,Jan Storek,John R. Wingard,Jo Anne H. Young,Michael Boeckh +8 more
TL;DR: Changes include the recommendations for PCV rather than PPSV-23 for pneumococcal vaccination, starting some vaccinations earlier post-transplant, and the addition of recommendations for Varivax, HPV vaccine, and (the non-use of) Zostavax vaccine are included.
Journal Article
Guidelines for Preventing Health-Care-- Associated Pneumonia, 2003 Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee
TL;DR: The new guidelines are designed to reduce the incidence of pneumonia and other severe, acute lower respiratory tract infections in acute-care hospitals and in other health-care settings (e.g., ambulatory and longterm care institutions) and other facilities where health care is provided.
References
More filters
Journal ArticleDOI
Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections
Frederick G. Hayden,Albert D. M. E. Osterhaus,John J. Treanor,D. M. Fleming,Fred Y. Aoki,Karl G. Nicholson,Arthur M. Bohnen,Hilary M. Hirst,Oliver N. Keene,Kevin Wightman +9 more
TL;DR: In adults with influenza A or B virus infections, direct administration of a selective neuraminidase inhibitor, zanamivir, to the respiratory tract is safe and reduces symptoms if begun early.
Journal ArticleDOI
Options for the control of influenza III. Cairns, North Queensland, Australia (4-9 May 1996).
TL;DR: The proceedings of the 1985, Viratek-UCLA Symposium; 1992-1996, International Conference on Options for the Control of Influenza; 2000-2000, World Congress on options for the control of influenza.
Journal ArticleDOI
A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection
TL;DR: Rimantadine appears to be the drug of choice for the prophylaxis of influenza A, as compared with placebo in a placebo-controlled, double-blind, randomized trial.
Journal ArticleDOI
Evidence for Zanamivir Resistance in an Immunocompromised Child Infected with Influenza B Virus
Larisa V. Gubareva,Mikhail Matrosovich,Malcolm K. Brenner,Richard C. Bethell,Robert G. Webster +4 more
TL;DR: The data indicate that the current methods for monitoring resistant mutants are potentially flawed because no tissue culture system adequately reflects the receptor specificity of human respiratory tract epithelium.
Journal ArticleDOI
Emergence and apparent transmission of rimantadine-resistant influenza A virus in families
Frederick G. Hayden,Robert B. Belshe,Richard D. Clover,Alan J. Hay,Marion G. Oakes,Whaijen Soo +5 more
TL;DR: It is concluded that when index patients are treated concurrently, rimantadine is ineffective in protecting household members from influenza A infection and rapid selection and apparent transmission of drug-resistant influenza A viruses can occur.